MTAP and acute lymphoblastic leukemia: They were detected in less than 3% of patients (except for the MTAP gene) among 382 AML (Fig. 2A) and 603 B-ALL (Fig. 2B) from the TCGA-LAML, AML and ALL TARGET cohorts, respectively.